Latest / Texas News Today | 2 Min News | The Daily News Now!
FDA Panel Faces Peptide Conflict | Texas News
Health advisors are weighing whether to greenlight seven controversial peptides—popular for wellness but lacking solid evidence of safety or efficacy—despite FDA scientists and medical experts urging caution. With Health Secretary Robert F. Kennedy Jr. pushing for relaxed rules, the panel includes several industry-connected doctors and pharmacists, raising conflict-of-interest concerns. While FDA staff recommend against compounding these hormone-affecting substances, the vote could pave the way for temporary access, potentially aligning with Kennedy’s agenda. Listen in comfort:Get a discount…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.